A randomized phase II study of maintenance hormone therapy with or without capecitabine after induction therapy with bevacizumab plus paclitaxel in hormone receptor positive and HER2 negative metastatic breast cancer (KBCSG-TR1214)

Yamaguchi Miki; Nakayama Takahiro; Yoshinami Tetsuhiro; Ikeda Masahiko; Iwamoto Mitsuhiko; Komoike Yoshifumi; Takashima Tsutomu; Tsurutani Junji; Yoshidome Katsuhide; Yamada Tomomi; Morita Satoshi; Masuda Norikazu

登录

免费注册

赞收藏引用

科研之友

微信

新浪微博

Facebook

分享链接

A randomized phase II study of maintenance hormone therapy with or without capecitabine after induction therapy with bevacizumab plus paclitaxel in hormone receptor positive and HER2 negative metastatic breast cancer (KBCSG-TR1214)

作者：Yamaguchi Miki; Nakayama Takahiro; Yoshinami Tetsuhiro; Ikeda Masahiko; Iwamoto Mitsuhiko; Komoike Yoshifumi; Takashima Tsutomu; Tsurutani Junji; Yoshidome Katsuhide; Yamada Tomomi; Morita Satoshi; Masuda Norikazu

来源：San Antonio Breast Cancer Symposium, 2017-12-05 to 2017-12-09.

出版日期2018-2

收藏分享被引浏览

更新时间：2018-11-23 12:35

相似论文
引用论文
参考文献

产品服务

科研之友科研之友机构版科创云

站内浏览

科研成果科研人员科研机构

服务支持

帮助中心隐私政策服务条款

联系方式

在线客服：【立即咨询】客户热线：400-1616-289 电子邮箱：support@scholarmate.com

微信公众号